Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adrenal Angiosarcoma: A Diagnostic Dilemma.

Literature DB >> 31612098

Adrenal Angiosarcoma: A Diagnostic Dilemma.

Nirav Antao¹, Michael Ogawa², Zarir Ahmed¹, Jinhua Piao³, Nishant Poddar².

Abstract

Primary angiosarcoma of the adrenal gland is both a rare and aggressive malignancy. Differentiating it from more common adrenal masses such as adrenal adenomas, adrenal cortical carcinomas, and metastatic carcinomas is one of several diagnostic challenges. Immunohistochemical analysis is imperative to arrive at the correct diagnosis. Treatment typically involves surgery and adjuvant chemotherapy, but prognosis remains poor.

Entities: Chemical Disease Gene Species

Keywords: adrenal angiosarcoma; adrenal cancer; adrenal mass; aggressive malignancy; immunohistochemistry

Year: 2019 PMID： 31612098 PMCID： PMC6784971 DOI： 10.7759/cureus.5370

Source DB: PubMed Journal: Cureus ISSN： 2168-8184

10 in total

1. Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor.

Authors: Ariel Grajales-Cruz; Francis Baco-Viera; Ernesto Rive-Mora; Carlos Ramirez-Tanchez; David Tasso; Norma Arroyo-Portela; Elizabeth Calderon; Ilean Joan Padua-Octaviani; William Caceres-Perkins
Journal: Cancer Control Date: 2017-04 Impact factor: 3.302

2. Primary epithelioid angiosarcoma of the adrenal gland.

Authors: A G Croitoru; A P Klausner; G McWilliams; P D Unger
Journal: Ann Diagn Pathol Date: 2001-10 Impact factor: 2.090

3. Combination chemotherapy in advanced adrenocortical carcinoma.

Authors: Martin Fassnacht; Massimo Terzolo; Bruno Allolio; Eric Baudin; Harm Haak; Alfredo Berruti; Staffan Welin; Carmen Schade-Brittinger; André Lacroix; Barbara Jarzab; Halfdan Sorbye; David J Torpy; Vinzenz Stepan; David E Schteingart; Wiebke Arlt; Matthias Kroiss; Sophie Leboulleux; Paola Sperone; Anders Sundin; Ilse Hermsen; Stefanie Hahner; Holger S Willenberg; Antoine Tabarin; Marcus Quinkler; Christelle de la Fouchardière; Martin Schlumberger; Franco Mantero; Dirk Weismann; Felix Beuschlein; Hans Gelderblom; Hanneke Wilmink; Monica Sender; Maureen Edgerly; Werner Kenn; Tito Fojo; Hans-Helge Müller; Britt Skogseid
Journal: N Engl J Med Date: 2012-05-02 Impact factor: 91.245

4. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.

Authors: Matthew G Fury; Cristina R Antonescu; Kimberly J Van Zee; Murray F Brennan; Robert G Maki
Journal: Cancer J Date: 2005 May-Jun Impact factor: 3.360

1 in total

1. Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel.

Authors: Hangping Wei; Jie Mao; Yandan Wu; Qinfei Zhou
Journal: Front Oncol Date: 2021-12-16 Impact factor: 6.244

1 in total

Adrenal Angiosarcoma: A Diagnostic Dilemma.

1. Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor.

2. Primary epithelioid angiosarcoma of the adrenal gland.

3. Combination chemotherapy in advanced adrenocortical carcinoma.

4. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.

5. A exceptional collision tumor of primary adrenal angiosarcoma and non-functioning adrenocortical adenoma.

6. Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience.

7. Angiosarcoma of the adrenal gland.

8. A mimic of sarcomatoid adrenal cortical carcinoma: epithelioid angiosarcoma occurring in adrenal cortical adenoma.

9. Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach.

10. A case report of primary adrenal angiosarcoma as depicted on magnetic resonance imaging.

1. Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel.